| |
|
Year ended
31 December
2003 £m
|
Year ended
31 December
2002
£m |
| Net operating exceptional items charged/(credited): |
|
|
|
| Deeside impairment |
|
– |
45 |
| Rugeley impairment |
|
– |
58 |
| Impairment of US plant |
|
404 |
– |
| Reversal of HUBCO impairment |
|
(35) |
– |
 |
|
 |
| Net operating exceptional items |
|
369 |
103 |
 |
|
 |
| Exceptional income from investments: |
|
|
|
| Backlog dividend received from KAPCO |
|
– |
(42) |
 |
|
 |
| Exceptional income from investments |
|
– |
(42) |
 |
|
 |
| Total operating exceptional items and investment income |
|
369 |
61 |
 |
|
 |
| Non-operating exceptional items credited: |
|
|
|
| Profit on disposal of a 5% holding in HUBCO |
|
(17) |
– |
| Profit on disposal of a Czech fixed asset investment |
|
(7) |
– |
| Release of provision in respect of sale of Chinese operations |
|
(3) |
– |
 |
|
 |
| Non-operating exceptional items |
|
(27) |
– |
 |
|
 |
| Exceptional interest charges: |
|
|
|
| Write off of unamortised finance charges |
|
16 |
– |
 |
|
 |
| Exceptional interest payable and similar charges |
|
16 |
– |
 |
|
 |
| Total exceptional items before attributable taxation |
|
358 |
61 |
 |
|
 |
| Taxation on exceptional items |
|
(26) |
(1) |
 |
|
 |
| Total exceptional items after attributable taxation |
|
332 |
60 |
 |
|
 |